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ABSTRACT
The multifunctional HCV core protein consists of a
hydrophilic RNA interacting D1 domain and a hydro-
phobic D2 domain interacting with membranes and
lipid droplets. The core D1 domain was found to
possess nucleic acid annealing and strand transfer
properties. To further understand these chaperone
properties, we investigated how the D1 domain and
two peptides encompassing the D1 basic clusters
chaperoned the annealing of complementary
canonical nucleic acids that correspond to the DNA
sequences of the HIV-1 transactivation response
element TAR and its complementary cTAR. The
core peptides were found to augment cTAR-dTAR
annealing kinetics by at least three orders of
magnitude. The annealing rate was not affected by
modifications of the dTAR loop but was strongly
reduced by stabilization of the cTAR stem ends, sug-
gesting that the core-directed annealing reaction is
initiated through the terminal bases of cTAR and
dTAR. Two kinetic pathways were identified with a
fast pre-equilibrium intermediate that then slowly
converts into the final extended duplex. The fast
and slow pathways differed by the number of base
pairs, which should be melted to nucleate the
intermediates. The three peptides operate similarly,
confirming that the core chaperone properties are
mostly supported by its basic clusters.
INTRODUCTION
Hepatitis C virus (HCV) (1) is an important human
pathogen transmitted mainly through blood contacts
and aﬀecting  170 million people worldwide (2).
Chronic infections are frequent and a major cause of
liver cirrhosis and cancer (3). HCV is an enveloped virus
of the Flaviviridae family, which has a positive-sense,
single-stranded RNA genome with an open-reading
frame encoding a polyprotein of 3010 amino acids or so
(4). The 50- and 30-ends of the viral RNA correspond to
non translated, highly structured and conserved regions
(50 UTR and 30 UTR) of 340 and 230 nucleotides, respec-
tively. The 50 UTR consists of ﬁve stem–loops (5) and
includes an internal ribosome entry site (IRES) that
directs translation of the HCV genome in a cap-
independent manner. The 30 UTR is composed of three
distinct parts: (i) a variable part with the VSL1 and VSL2
stem–loops, (ii) a poly (U/UC) tract and (iii) a sequence X
of 98 nucleotides (6,7). Deletion of the U-rich and X
sequence results in a loss of virus replication and
infectivity (8).
The polyprotein precursor is co- and post-
translationally processed by cellular and viral proteases
at the endoplasmic reticulum (ER) membrane to yield
the mature structural and nonstructural proteins. The
structural proteins include the core and the envelope
glycoproteins E1 and E2 (9). The N-terminal end of the
polyprotein, which is a major HCV antigen (10,11), is
cleaved by a cellular signal peptidase, generating the
core of 191 residues which binds the ER membrane (12).
This protein is then processed by a signal peptide
peptidase (13,14), giving a mature protein of 179
residues or so, which is targeted to the lipid droplets
(LDs) (15–17). Apart from LDs, the protein can be
retained at the ER membrane and localized on
mitochondria (15,18). The mature protein is a dimeric,
alpha-helical protein exhibiting features that are consis-
tent with those of a membrane protein (19) . It consists
of a basic N-terminal RNA binding domain D1 (aa 2–117)
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(20), and a hydrophobic C-terminal domain D2 (aa 118–
179 or so) involved in targeting the protein to LDs (21).
Core attachment to LDs is critical for assembly and
release of infectious HCV particles (HCVcc) (22).
The core exerts multiple roles in infected cells and virus
replication. The core notably interacts with a number of
cellular proteins which impacts on cell proliferation and
diﬀerentiation (10,23) and also on the lipid metabolism
with a possible inﬂuence on hepatocellular carcinomas
(24). As a major viral component tightly binding to
genomic RNA sequences, the core is also thought to
drive genomic RNA packaging and nucleocapsid forma-
tion (25–27). Moreover, the core has potent nucleic acid
chaperoning activities (20,28), similar to retroviral nucleo-
capsid (NC) proteins (29–35). Through this activity, the
core can resolve RNA misfolding and promote annealing
of complementary sequences and strand exchanges (28).
This activity appears to be mediated by the three basic
clusters (BD1–BD3) of the D1 domain (20,28).
To further characterize the core RNA chaperone pro-
perties, we investigated how the D1 domain and peptides
encompassing the basic clusters direct the annealing
of complementary DNA sequences represented by the
canonical model of the HIV-1 transactivation response
(TAR)(36) element in a DNA form (dTAR) and the com-
plementary sequence cTAR. The extremely slow annealing
of these two sequences is drastically accelerated by
addition of a retroviral NC protein (30,32,34) or the
HCV core (28). The nucleocapsid protein NCp7 of
HIV-1 activates the transient opening of the cTAR
terminal base-pairs (29,37) causing a partial melting of
the stem (33,38). These partly melted TAR DNAs
anneal then through their termini to form an intermediate
complex which is further converted into the ﬁnal extended
duplex (ED) (30,33,35). To determine whether the HCV
core promotes cTAR/dTAR annealing through a similar
molecular mechanism, we monitored the real-time
annealing kinetics of ﬂuorescently labelled cTAR with
dTAR and mutants thereof in the presence of D1
Domain, and peptides E and F corresponding to the two
(BD2 and BD3) and all three (BD1, BD2 and BD3) basic
clusters, respectively. Results indicate that the three core
peptides destabilize cTAR and dTAR secondary struc-
tures to a small extent, but eﬃciently promote dTAR/
cTAR annealing through the dTAR and cTAR ends.
MATERIALS AND METHODS
Core peptides and oligonucleotides
Peptides E and F were synthesized by solid-phase peptide
synthesis on a 433A synthesizer (ABI, Foster City, CA,
USA) as described (20). Puriﬁcation by HPLC was carried
out on a C8 column (Uptisphere 300A, 5mm; 250 10,
Interchim, France) in 0.05% TFA with a linear gradient
of 10–70% of acetonitrile for 30min. The peptide purity
and molecular weight (6754 for peptide E and 9444 for
Peptide F) were checked by LC/MS. Absorption coeﬃ-
cient of 5700M
–1cm
–1 at 280nm was used to determine
their concentration.
The D1 domain consisting of amino acids 1–117 of the
core protein fused to a C-terminal 6xHis tag was prepared
as previously described (19).
The unlabelled and the labeled ODNs were synthesized
by IBA GmbH Nucleic Acids product Supply (Gottingen,
Germany). In the case of the doubly labeled ODNs, the 50
terminus was labeled with carboxytetramethylrhodamine
(TMR) or ethyl 2-[3-(ethylamino)-6-ethylimino-2,
7-dimethylxanthen-9-yl]benzoate hydrochloride (Rh6G)
via an amino-linker with a six carbon spacer arm, while
the 30 terminus was labeled with either 4-(40-dimethylami-
nophenylazo) benzoic acid (Dabcyl) or 5(and 6)-carbo-
xyﬂuorescein (Fl) using a special solid support with the
dye already attached. ODNs were puriﬁed by the manu-
facturer by reverse-phase HPLC and polyacrylamide gel
electrophoresis.
Experiments were performed in 25mM Tris–HCl
(pH 7.5), 30mM NaCl and 0.2mM MgCl2 at 20 C.
Fluorescence measurements
Emission spectra and kinetic traces were recorded
with Fluorolog and FluroMax spectroﬂuorimeters
(Jobin Yvon Instruments, S.A. Inc.) equipped with a
temperature-controlled cell compartment. All ﬂuorescence
intensities were corrected for buﬀer emission and Lamp
ﬂuctuations.
Kinetic measurements were performed in pseudo
ﬁrst-order conditions by using concentrations of
unlabelled TAR and dTAR at least 10-fold higher than
the concentration of the labeled complementary sequence.
Excitation and emission wavelengths were 520 and
550nm, respectively, to monitor the Rh6G ﬂuorescence.
The corresponding wavelengths were 480 and 520nm,
respectively to monitor the Fl ﬂuorescence. All reported
concentrations correspond to those after mixing. To avoid
high local concentrations during mixing, both reactant
mixtures were prepared of the same volume. Peptides
were added to each reactant separately, and then the
reaction was initiated by mixing the peptide-coated
ODNs together. The kinetics was fast enough to monitor
the ﬂuorescence intensities continuously without photo-
bleaching. The apparent rate constants kobs and the ampli-
tudes were determined from the kinetic traces by including
a dead-time correction t0 to take into account the delay
between the mixing of reactants and the start of the mea-
surements. All ﬁtting procedures were carried out with
Origin
TM 7.5 software based on nonlinear, least-square
methods and the Levenberg-Marquardt algorithm.
The temperature dependence of the annealing kinetics
was carried out with 10nM doubly labeled cTAR deriva-
tives and 300-nM nonlabeled dTAR derivatives at diﬀer-
ent temperatures (10 C, 20 C, 25 C, 30 C, 35 C and
40 C) in the presence of either peptide E, peptide F and
Domain D1, added at a peptide to oligonucleotide ratio
of 1.4:1.
Fluorescence correlation spectroscopy setup
and data analysis
Fluorescence correlation spectroscopy (FCS) measure-
ments were performed on a two-photon platform
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described previously (37,39). Two-photon excitation at
850nm is provided by a mode-locked Tsunami
Ti:sapphire laser pumped by a Millenia V solid-state
laser (Spectra Physics, USA). The experiments were per-
formed in an eight-well lab-Tek II coverglass system, using
a 400-ml volume per well. The focal spot was set about
20mm above the coverslip. Peptide E was added to the
labeled cTAR sequences at diﬀerent nucleotide to
peptide ratios. To avoid high local concentrations during
mixing, both reactants were of the same volume.
Assuming that peptide E diﬀuses freely in a Gaussian exci-
tation volume, the normalized autocorrelation function,
G( ), calculated from the ﬂuorescence ﬂuctuations was
ﬁtted according to (40):
Gð Þ¼
1
N
1 þ
 
 d
  1
1 þ
1
S2
 
 d
  1=2
ð1Þ
where  d is the diﬀusion time, N is the mean number of
molecules within the excitation volume and S is the ratio
between the axial and lateral radii of the excitation
volume. The point spread function of the set-up was deter-
mined from a z-scan on one ﬂuorescent bead (20nm in
diameter). The measured lateral and axial resolutions
were respectively 0.3 and 1mm. Typical data recording
times were 10min. Twenty autocorrelation curves were
recorded for each sample. When spikes of high ﬂuores-
cence intensity, most likely associated to aggregates,
were observed in the ﬂuorescence ﬂuctuation proﬁles, the
corresponding autocorrelation curves were discarded. In
these conditions, the average autocorrelation curve
calculated from the sum of the remaining autocorrelation
curves could be adequately ﬁtted by a single population
model with a diﬀusion time close to that of cTAR alone.
RESULTS
Investigating the interaction of cTAR DNA
with the core peptides by FCS
To characterize in depth the nucleic acid chaperone
properties of the core protein, we ﬁrst had to ﬁnd exper-
imental conditions where the core peptides did not cause
DNA aggregation in a manner similar to other nucleic
acid chaperones (32,34,41,42). Indeed, molecular aggrega-
tion can cause strong bias when using ﬂuorescence-based
techniques (30,32). Since nucleic acid aggregation by pos-
itively charged peptides is concentration dependent
(42,43), we investigated this dependence by means of
FCS. In FCS, the ﬂuorescence intensity arising from a
very small volume (about 0.2fL) is correlated to obtain
information about the processes that give rise to ﬂuores-
cence ﬂuctuations. These ﬂuctuations are mainly governed
by the diﬀusion of ﬂuorescent species throughout this
volume, and thus parameters such as the average
number of ﬂuorescent species within this volume and
their diﬀusion constant can be determined. As a conse-
quence, aggregation of the TMR-labeled 50-cTAR mole-
cules by the core peptides would be expected to decrease
the number of ﬂuorescent species.
Experiments were performed at two diﬀerent ODN con-
centrations (100 and 300nM). In the absence of peptide,
the number of ﬂuorescent TAR molecules in the excitation
volume was fully consistent with the theoretical number of
molecules expected from their concentration. By adding
increasing concentrations of either core peptide, we
found no change in the number of ﬂuorescent species up
to a peptide/ODN molar ratio of 1.4:1, indicating that no
aggregation occurred under these conditions (Figure 1).
In contrast, aggregation took place at higher ratios
(2.8:1 and 5.6:1) as evidenced by the sharp drop in the
number of ﬂuorescent species. Changes in the diﬀusion
constant were also observed at these higher ratios but
were less prominent (data not shown), due to the depen-
dence of the diﬀusion constant on the cubic root of the
molecular mass of the diﬀusing species. As a consequence,
we selected a peptide/ODN molar ratio of 1.4:1 to char-
acterize the chaperone properties of the core peptides.
Destabilization of cTAR secondary structure by the
core peptides
Since destabilization of nucleic acid secondary structures
is a feature of the chaperone protein activity
(29,32,37,41,44), we characterized the nucleic acid
destabilizing activity of the core peptides, using cTAR
labeled at its 50 and 30 ends by Rh6G and Dabcyl, respec-
tively. In the absence of peptide, the proximity of cTAR
ends induces a strong ﬂuorescence quenching of Rh6G by
the Dabcyl group (37), while the melting of the lower half
of the cTAR stem increases the distance between the two
dyes and thus, restores Rh6G ﬂuorescence. Thus, the
destabilizing activity of the core peptides can be evaluated
from the ratio of the ﬂuorescence intensity with or with-
out the peptide. Addition of core peptides E and F
at a peptide/cTAR molar ratio of 1.4:1 led to a 1.5-fold
increased ﬂuorescence intensity for Rh6G-50-cTAR-
30-Dabcyl, while no change was observed with the D1
domain (Figure 2). Since full melting of cTAR would
lead to a 20- to 25-fold increase of the Rh6G ﬂuorescence,
<10% of the Rh6G ﬂuorescence was restored upon
binding of the core peptides. No further increase was
observed with either peptide at higher ratios (data not
shown), possibly due to the ﬂuorescence quenching
related to formation of aggregates. Thus, in contrast to
retroviral NC proteins (30–32,37), the core peptides can
only slightly destabilize the secondary structure of cTAR,
in the present experimental conditions.
Kinetics of cTAR/dTAR annealing in the presence of
peptide E
To characterize the mechanism by which the core protein
can activate the annealing of the complementary cTAR
and dTAR sequences, we ﬁrst used the peptide E, which
was easy to synthesize in large quantities and was
previously shown to mimic the core chaperone properties
(20,28). The real-time annealing kinetics of cTAR
to dTAR was monitored by mixing Rh6G-50-cTAR-
30-Dabcyl with an excess of non-labeled dTAR, in the
presence of peptide E added at a peptide/ODN ratio of
1.4:1. Formation of the 55-bp ED strongly increases the
3634 Nucleic Acids Research, 2010,Vol.38, No. 11interchromophore distance, leading to a full recovery of
Rh6G emission (29). The same ﬂuorescence plateau was
obtained as in the absence of peptide, indicating that ED
formation went to completion (Figure 3A). Peptide E
strongly accelerated the annealing reaction, since it was
complete in <30min, while it needed more than 24h in
the absence of peptide (30). As shown by the nearly
random distribution of residuals around the zero value
(Figure 3B), the annealing kinetic traces could be ade-
quately ﬁtted using a biexponential function:
I ðtÞ¼If  ðIf  I0Þ ae ð kobs1 ðt t0ÞÞ  ð1   aÞ eð kobs2 ðt t0ÞÞ 
ð2Þ
where, t0 being the dead time, kobs1,2 are the observed
kinetic rate constants, a is the amplitude of the fast com-
ponent, and I0 and If are the ﬂuorescence intensities of the
stem–loop and the ED, respectively.
The dTAR concentration dependence indicates a satu-
ration behavior for both kobs1 and kobs2 values (Figure 4),
consistent with a two-step reaction, where a rate-limiting
interconversion step is coupled to a much faster, preceding
binding step, considered as a pre-equilibrium:
cTAR þ dTARÐ
KM
ICÐ
kf
kb
ED ð3Þ
where IC corresponds to the intermediate complex. The
dTAR concentration dependence of both kobs values was
ﬁtted using (45):
kobs ¼
kfKM½dTAR 
1 þ KM½dTAR 
þ kb ð4Þ
Values of 4 (±2) 10
6M
–1 and 1.4 (±0.7) 10
6M
–1
were obtained for KM1 and KM2, the equilibrium binding
constants of the intermediate complexes associated with
the fast and slow kinetic component, respectively.
Moreover, values of 0.045 (±0.008)s
–1 and 0.016
(±0.002)s
–1 were obtained for the sum of the forward
(kf1, kf2) and backward (kb1,k b2) interconversion rate con-
stants associated to the two kinetic components. The
values of kb1 and kb2, given by the intercept, were very
low (<0.001s
–1) and could not be determined from
the experimental data, indicating that peptide E is
unable to dissociate the ED, and that the 0.045s
–1 and
0.016s
–1 values mainly correspond to kf1 and kf2,
respectively.
Noticeably, substitution of the Rh6G and Dabcyl dyes
at the 50- and 30-ends of cTAR by TMR and Fl, respec-
tively, had a marginal inﬂuence on the kinetic parameters
(Table 1), indicating that the peptide E-promoted cTAR/
dTAR annealing kinetics does not depend on the nature of
the dyes.
In contrast to the kobs values, the amplitudes of the two
components (Table 1) were independent of dTAR concen-
tration (data not shown), suggesting that peptide
E-promoted annealing reaction involves two parallel
pathways. To conﬁrm this, we repeated the annealing
reaction at a peptide/ODN molar ratio of 1:1. At this
lower ratio, the amplitudes of the two components were
also independent of dTAR concentration, but with a
decreased value for the fast component as compared to
the 1.4:1 ratio, in line with the hypothesis of two parallel
pathways. Moreover, while the KM1 and KM2 values were
three to four times lower than at the higher ratio, the
interconversion rate constants were similar (Table 1), sug-
gesting that peptide E mainly aﬀects the pre-equilibrium
step.
On the basis of our kinetic data, a reaction mechanism
with two parallel kinetic pathways involving two diﬀerent
Figure 1. Evidence by ﬂuorescence correlation spectroscopy of core
peptide-induced aggregation of TMR-50-cTAR. The average number
of ﬂuorescent species, N, for 100nM (black squares) or 300nM
(magenta circles) of TMR-50-cTAR within the excitation volume was
obtained by ﬁtting the autocorrelation curves to Equation (1). The
curves are given with peptide E. Data with peptide F and D1
domain were very similar and were thus not represented. (Inset)
Autocorrelation curves of 100nM (blue line) and 300nM
TMR-50-cTAR (green line) and their ﬁts (black line) with Equation
(1) in the presence of 140nM and 420nM of peptide E, respectively.
Figure 2. Destabilization of cTAR secondary structure by core
peptides. Emission spectra of Rh6G-cTAR-Dabcyl (100nM) were
recorded in the absence (black) and presence of peptide E (magenta),
peptide F (blue) and D1 Domain (green) at a molar ratio of 1.4 peptide
per cTAR in 25mM Tris, 30mM NaCl and 0.2mM MgCl2, pH 7.5.
Excitation wavelength was 520nm.
Nucleic Acids Research, 2010,Vol.38, No. 11 3635cTAR/peptide E complexes (cTAR1 and cTAR2) can be
proposed:
Scheme 1
KM1
KM2
IC1
IC2
ED
kf1
cTAR2 +d T A R k f2
cTAR1 +d T A R
where IC1 and IC2 are the intermediate complexes of the
fast and slow pathways, respectively, and kf1 and kf2 are
the corresponding interconversion rate constants. Further
insights into nature of the two pathways were obtained
from the temperature dependence of the kobs values,
using the Arrhenius equation:
ki ¼ Ai exp Ea,i=RT ðÞ ð5Þ
where the rate constant ki is given by kobsi/[dTAR], Ai
is the pre-exponential Arrhenius factor, Ea,i is the activa-
tion energy, R is the universal gas constant and T is the
temperature (in Kelvin).
Both reaction rates as well as the amplitude of the fast
pathway increased with temperature (Figure 5). Positive
enthalpy values for the transition state of 9.5(±0.6)kcal/
mol and 24(±1)kcal/mol for the fast and slow pathways,
respectively, were obtained. These values indicate that
cTAR/dTAR annealing promoted by the core peptide
involves pre-melting of  2 and 5bp, for the fast and
slow pathways, respectively (46,47). Moreover, since the
fast pathway represents 100% at 40 C (Figure 5), it is
necessarily associated with ED formation and thus
diﬀers from the unproductive fast pathway observed for
the cTAR/dTAR annealing reaction promoted by the
HIV-1 NC (11-55) mutant (30).
Eﬀects of oligonucleotide sequence and stability on the
annealing kinetics promoted by the core peptide E
To further characterize how the core peptide inﬂuenced
the annealing kinetics, we investigated the impact of the
oligonucleotide sequence and stability on the reaction.
First, dTAR was substituted by the dTAR T-L mutant
where the 6nt of the loop were changed to T residues
(Figure 6), thus preventing base-pairing with the cTAR
loop. These nucleotide substitutions did not signiﬁcantly
change the kinetic parameters of the two pathways
(Table 1) and ED formation (Figure 7), indicating that
loop–loop interactions do not play a signiﬁcant role in
peptide E-promoted cTAR/dTAR annealing reaction.
To investigate the role of the cTAR stem in the
annealing reaction, we used the cTAR1,2 derivative
where bases complementary to the bulged bases at posi-
tions 49 and 52 have been introduced in order to stabilize
the lower half of the stem (Figure 6). This mutant was
previously shown to be about four times more stable
than cTAR (44). Peptide E did not cause a ﬂuorescence
change of the doubly labeled cTAR1,2 (data not shown),
indicating that peptide E was unable to destabilize the
mutated stem. Moreover, the annealing of this mutant
to dTAR in the presence of peptide E was extremely
slow (Figure 7) with one kinetic pathway and a 10-fold
decrease in the values of the pre-equilibrium constant, KM,
and the interconversion rate constant, kf (Table 1). Thus,
in a manner similar to NCp7 (30,35,48), peptide E nucle-
ates cTAR/dTAR annealing probably through the cTAR
and dTAR ends. This is conﬁrmed by the increased value
of the transition state enthalpy (30(±2)kcal/mol),
indicating that the rate-limiting step of the peptide-
promoted cTAR1,2/dTAR annealing involves melting of
the stabilized cTAR1,2 stem (46). Moreover, the decreased
Figure 3. Kinetics of cTAR/dTAR annealing in the presence of peptide
E. (A) Kinetic trace of 10nM doubly labeled cTAR reacted with 300nM
dTAR in the presence of peptide E added at a peptide/ODN molar ratio
of 1.4:1. The continuous line describes the best ﬁt of the data according
to equation (2) with kobs1=1.8 10
–2s
–1, kobs2=2.8 10
–3s
–1 and
a=0.7. Inset: emission spectra of the doubly labeled cTAR in the
presence of peptide E added at a peptide/ODN ratio of 1.4:1 before
(magenta) and after completion of the annealing reaction with dTAR
(green). (B) Weighted residuals for the ﬁt of the experimental data to
Equation (2).
Figure 4. Kinetic parameters of cTAR/dTAR annealing in the presence
of peptide E. The fast (kobs1) and slow (kobs2) (inset) components were
determined in pseudo-ﬁrst-order conditions from real-time kinetics, as
described in Figure 3. The solid line corresponds to the ﬁt of the data
with Equation (4) and the KM and kf values given in Table 1.
3636 Nucleic Acids Research, 2010,Vol.38, No. 11stability of the cTAR1,2/dTAR intermediate as compared
with the cTAR/dTAR one, most probably results from the
base pair mismatches in the intermediate due to the addi-
tional bases in cTAR1,2 stem, further supporting the
notion that the annealing reaction is nucleated through
the stem ends.
Substitution of dTAR by TAR RNA also caused a sig-
niﬁcant decrease of the annealing reaction promoted by
peptide E (Figure 7), due to a decrease in the amplitude of
the fast component together with a 10-fold decrease of the
interconversion rate, kf2 of the slow pathway (Table 1).
This reduced annealing rate is likely caused by the higher
stability of the TAR stem (29), suggesting that as with
HIV-1 NCp7 (30,33,35), the cTAR/TAR annealing
reaction promoted by peptide E is probably starting
from the stem. This conclusion is further supported by
the similar values of the transition state enthalpies (data
not shown) and the equilibrium binding constants of the
reaction intermediates (Table 1) in the cTAR/dTAR,
cTAR/dTAR T-L and cTAR/TAR annealing reactions,
indicating that the ICs in all these systems are stabilized
by a similar number of base pairs.
To further conﬁrm the critical role of the cTAR stem
end, we investigated the annealing kinetics with the
(14-39)cTAR derivative, also called mini-cTAR (49), in
which the lower half of cTAR stem has been deleted
(Figure 6). This cTAR mutant was previously shown to
be about twice more stable than the entire cTAR (50). The
annealing of (14–39)cTAR/dTAR in the presence of core
peptide E was much slower than that of cTAR/dTAR
(Figure 7), and exhibited only one kinetic pathway, con-
ﬁrming that the peptide E-promoted cTAR/dTAR
annealing is nucleated through the cTAR ends.
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Figure 5. Temperature dependence of cTAR/dTAR annealing kinetics
in the presence of peptide E at ratio 1.4:1. The reaction was performed
with 10nM doubly labeled cTAR and 300-nM non-labelled dTAR. The
natural logarithm of the rate constant values for the fast (black
squares) and slow (black triangles) components as well as the amplitude
of the fast component (open circles) are indicated at six diﬀerent tem-
peratures. The solid magenta lines are the best ﬁt to Equation (5) with
Ea1=9.5(±0.6)kcal/mol and Ea2=24(±1)kcal/mol, for the fast and
slow components, respectively. It was checked that no aggregation was
associated with the changes in temperature.
Nucleic Acids Research, 2010,Vol.38, No. 11 3637Substitution of (14-39)cTAR by (14-39)cTAR-TL, in
which the 6nt of the (14-39)cTAR loop were substituted
with T residues (Figure 6), further decreased the annealing
reaction rate (Figure 7). This suggests that as for NCp7
(51), the(14-39)cTAR/dTAR annealing reaction promoted
by peptide E may partially be nucleated through kissing
loop intermediates. This conclusion was further supported
by the value of the transition state enthalpy 15(±5)kcal/
mol, that perfectly matches the value found with the
NCp7-promoted annealing of mini-cTAR (51).
Taken together, our data indicate that both kinetic
pathways of the peptide E-promoted cTAR/dTAR
annealing reaction are nucleated through the stems.
Promotion of cTAR/dTAR annealing by peptide F
and D1 domain
Next, we investigated cTAR/dTAR annealing in the
presence of peptide F and the D1 domain to determine
whether they promote the annealing reaction through the
same mechanism as peptide E (Figure 6B). The annealing
kinetics in their presence was also biphasic with a hyper-
bolic dependence of kobs1,2 values and a constant ampli-
tude value of about 0.8, strongly suggesting that the three
core peptides promote cTAR/dTAR annealing by the
same mechanism. While the three peptides provide
Figure 6. Sequences of the HCV core protein (A) and the peptides (B) and oligonucleotides (C) used in this study. The N-terminal D1 domain of the
core protein (B) comprises three regions rich in basic residues (BD1 to BD3) and a region rich in tryptophan residues (WD). Peptides E and F
correspond to the association of two (BD2 and BD3) and all three (BD1, BD2 and BD3) basic clusters, respectively. The NC(11–55) peptide
corresponds to the zinc ﬁnger domain of the HIV-1 nucleocapsid protein. The cTAR and TAR RNA sequences (c) are from the HIV-1 MAL strain.
The secondary structures of the oligonucleotides were predicted from the structure of TAR (36) and the mfold program (http//www.bioinfo.rpi.
edu/applications/mfold/old/dna/form1.cgi).
Figure 7. Kinetics of peptide E-promoted annealing of cTAR deriva-
tives with TAR or dTAR derivatives. Kinetic traces of 10nM doubly
labeled cTAR derivatives with 300nM nonlabeled TAR or dTAR
derivatives [cTAR/dTAR (cyan), cTAR/dTAR-TL (green), cTAR/
TAR RNA (red), (14-39)cTAR/dTAR (magenta), (14-39)cTAR-TL/
dTAR (orange) and cTAR1,2/dTAR (yellow)]. Black lines correspond
to ﬁts of the kinetic curves with Equation (2) and the parameters in
Table 1. Peptide E was added at a peptide/oligonucleotide ratio of 1.4:1
in all the cases and experimental conditions were as in Figure 3.
3638 Nucleic Acids Research, 2010,Vol.38, No. 11similar values for the pre-equilibrium binding constants,
they diﬀer in the interconversion rate constants. Indeed,
the interconversion rates of the intermediates to ED were
about 3- to 7-fold faster with peptide F than that with
peptide E and the D1 domain (Table 1).
Interestingly, the temperature dependence of the kobs
values with peptide F and domain D1 yielded enthalpy
values that were similar to those with peptide E (data
not shown), conﬁrming that the three peptides follow
the same mechanism by nucleating ICs with a similar
number of base pairs.
Comparison of the three peptides suggests that the
third basic domain (BD3) favors the interconversion
step while the additional sequences in D1, notably the
tryptophan-rich domain, WD, have a counter eﬀect.
Comparison of HCV core peptide E and HIV-1 NCp7
in promoting cTAR/dTAR annealing
Since both peptide E and NCp7 promote cTAR/dTAR
annealing, this prompted us to compare their eﬃciencies
in this activity. Because wild-type NCp7 strongly aggre-
gates oligonucleotides (30,42,52,53), we used the truncated
NC (11-55) peptide (Figure 6B), which mimics the
activities of NCp7 without aggregation (30,38).
Comparison of peptide E with NC(11-55) at several
molar ratios revealed that 1 and 1.4 molecules of peptide
E provided the same annealing activity as that of 4 and 6
NC (11-55) molecules (Figure 8A), respectively. This
suggests that one peptide E molecule exhibits nearly the
same chaperone activity as 4 molecules of NC(11-55).
Furthermore, the kinetic traces in the presence of both
NC(11-55) added at a ratio of 4 peptides per
oligonucleotide and peptide E added at ratios of 1 and
1.4 peptides per oligonucleotide were similar to the
kinetic traces obtained with ratios of 8 and 10
NC(11-55) per oligonucleotide, respectively (Figure 8B).
This conﬁrmed that one peptide E exhibits the same
chaperone activity as four NC(11-55) and favored the
notion that the two peptides can chaperone in concert
the annealing of the two complementary ODNs.
DISCUSSION
The aim of the present study was to characterize the
mechanism by which the basic domain of the HCV core
chaperones the annealing of two canonical complemen-
tary stem–loop sequences, namely the HIV-1 cTAR
and dTAR DNA, which have been extensively used to
study the chaperone properties of retroviral NC proteins
(30,32–35,54–56). This study was performed with the D1
core domain and two peptides that encompass the basic
clusters critical for the chaperone properties of the core
(20,28). To maintain the nonaggregating conditions
required for the present ﬂuorescent experiments, we used
a limited peptide to oligonucleotide molar ratio of 1.4:1.
In contrast to retroviral NCs, such as HIV-1 NCp7 and
MuLV NCp10 (29,32), the core peptides exhibit only a
slight destabilizing activity, suggesting that this compo-
nent plays a limited role in the core-promoted annealing
reaction. Nevertheless, these peptides eﬃciently activate
the cTAR/dTAR annealing reaction as shown by the up
to three orders of magnitude diﬀerence in the values of the
overall kinetic constants (kass=KM kf) in the presence
of the core peptides (Table 1) as compared to the
bimolecular rate constant (85M
–1s
–1) in their absence
(30). The promotion of cTAR/dTAR annealing by the
core peptides was found to start from the cTAR end
and to proceed through two parallel kinetic pathways
that include a fast pre-equilibrium intermediate and a
rate-limiting conversion into the ﬁnal ED. The fast and
slow pathways likely diﬀer by the number of base pairs
( 2 and 5, respectively) that should be melted in the
original cTAR secondary structure to nucleate the ICs.
Since thermally driven fraying of cTAR termini occurs
spontaneously at room temperature (29,37,44), the fast
pathway is probably associated with a cTAR species
where the 3bp of the terminal stem are melted, while the
slow pathway may be associated with the fully structured
oligonucleotide (Figure 9). Therefore, formation of IC1
in the fast pathway is thought to involve the melting of
the 2bp from the penultimate double-stranded segment
while the 5bp of both terminal and penultimate double
Figure 8. Comparison of the chaperoning properties of peptide E and HIV-1 NC(11-55). Kinetic traces were recorded with 10nM doubly labeled
cTAR and 100nM nonlabeled dTAR. (A) Kinetic traces in the presence of NC (11-55) added at a peptide/oligonucleotide molar ratio of 4 (red), 5
(cyan) and 6 (magenta) or in the presence of peptide E added at a molar ratio of 1:1 (yellow) and 1.4:1 (green). (B) Kinetic traces with NC (11-55)
added at a peptide/oligonucleotide molar ratio of 4:1 in the presence of peptide E, added at a peptide/oligonucleotide molar ratio of 1:1 (red) and
1.4:1 (cyan) compared with only NC (11–55) added at a molar ratio of 8:1 (green) and 10:1 (yellow) respectively. Black lines correspond to ﬁts of the
kinetic curves with Equation (2).
Nucleic Acids Research, 2010,Vol.38, No. 11 3639stranded DNA segments should melt to form IC2 in the
slow pathway. As previously shown with HIV-1 NCp7
(35) and Tat (submitted), IC1 may result from the
annealing of both 30 and 50 terminal strands of cTAR
with the complementary terminal strands of dTAR and
be stabilized by 12 intermolecular base pairs. Since the
IC2 complex in the slow pathway is less stable than IC1,
it likely involves a smaller number of intermolecular base
pairing. A possible explanation is that IC2 results from an
invasion mechanism, in which only one cTAR strand
anneals with the complementary dTAR strand (54,56),
allowing the formation of 5–7 intermolecular base pairs.
Both IC1 and IC2 are further converted into the ED,
which most probably relies on the conformational
rearrangement and melting of the stable upper part of
both TAR species. In this respect, the 3- to 4-fold faster
interconversion rate of IC1 as compared to IC2 probably
results from its larger number of intermolecular base pairs
and/or more favorable conformation for the subsequent
conversion into the ED.
Interestingly, the degree of coating of cTAR and dTAR
by the peptides was found to strongly aﬀect the equilib-
rium binding constant of the ICs but not their
interconversion rate. Moreover, the amplitude of the fast
component increases with the coating degree, suggesting
that a single pathway can probably take place at a
saturating concentration of core peptide, as in the case
of retroviral proteins (35,49,51). In the proposed model
reaction (Figure 9), the amplitude of the fast component
is a complex function of the fast equilibrium between
cTAR1 and cTAR2 species, their stability, their initial
melting by the peptides and the ﬂuorescence intensity of
the intermediates. Accordingly, the amplitude of the fast
component decreased, when either of the two partners,
cTAR or dTAR, was substituted by a more stable one
( 35% for cTAR/TAR and <5% cTAR1,2/dTAR) as
compared to 70% for cTAR/dTAR. On the other hand,
a decrease in stability of partners results in an increase of
amplitude (100% at 40 C for cTAR/dTAR). Finally, the
core chaperone mechanism was found to be similar for
peptide E, peptide F and D1 domain, conﬁrming that
the basic clusters are the main determinants in this mech-
anism (20,28).
Comparison with the truncated HIV-1 NC(11-55)
peptide revealed that one core peptide molecule exhibits
the same chaperone activity as four NC(11-55) molecules
in cTAR/dTAR annealing (Figure 8). A similar conclu-
sion applies for cTAR/TAR RNA annealing with the
full-length NCp7, since the KM values of the ICs with
peptide E (about 10
6M
–1) are similar to the corresponding
KM value obtained with NCp7 added at a ratio of six
proteins per oligonucleotide (35). This suggests that a
1.4 equivalent of peptide E could be as active as 6 NCp7
equivalents in the present experimental conditions. This is
likely a consequence of the stronger ‘nucleic acid
aggregating’ properties of the core peptides, in line with
the eﬃcient oligonucleotide aggregation observed by FCS
(Figure 1). This propensity of the core peptides to neutral-
ize the negatively charged nucleic acids and to promote
their aggregation is probably related to the highly ﬂexible
nature of the core peptides (19,57) as compared to the
folded NCp7 structure with two zinc ﬁngers (58,59). In
addition, NCp7 and the core peptides likely diﬀer on
how they promote the interconversion reaction. For
cTAR/TAR, the interconversion rate constant, in the
absence of any peptide is about 1.5 10
–4s
–1, while it is
about 3-fold higher in the presence of NCp7, at any
protein/oligonucleotide ratio (35). For the core peptides,
the corresponding values for the fast and slow pathway
are respectively, two and one order of magnitude higher
than in the absence of protein. Thus, in contrast to NCp7,
the core peptides strongly favor the interconversion
reaction, which is thought to be rate-limited by a confor-
mational change involving cooperative melting of a large
fragment of one or both hairpin stems. Moreover, while
NCp7 also promotes cTAR/TAR annealing through
kissing loop intermediates when added at sub-saturating
concentrations to ODNs (35), the core peptides mainly
chaperone the annealing through the stems.
Taken together, our data suggest that though at
sub-saturating conditions, the core peptides only margin-
ally destabilize the secondary structure of oligonucleo-
tides, they are more eﬃcient than the truncated HIV-1
NC(11-55) peptide in nucleating IC formation through
their nucleic acid aggregation properties and promoting
the subsequent IC conversion into ED. Moreover, in
Figure 9. Proposed mechanism for core-promoted cTAR/dTAR
annealing. The annealing reaction at sub-saturating protein concentra-
tions is thought to involve two pathways that rely on thermal fraying of
cTAR. This fraying leads to a fast equilibrium (microsecond range)
between the fully closed cTAR species (cTAR2) and a partially
melted cTAR species (cTAR1) (37). The upper pathway (steps a and
b) and the lower pathway (steps a0 and b0) are associated with the fast
and the slow kinetic components, respectively. In both pathways, the
cTAR species nucleate an intermediate complex (IC) that subsequently,
converts in a rate-limiting step to the ﬁnal extended duplex (ED).
In both pathways, the ICs are nucleated through the stem termini.
3640 Nucleic Acids Research, 2010,Vol.38, No. 11contrast to NC(11-55) and native NCp7 (35) which
requires high peptide/ODN ratios for optimal activity,
the core peptides already show strong nucleic acid
annealing activity at low peptide/ODN ratios, suggesting
that the core protein can exert its strong chaperone
activity at low fractional saturation of nucleic acids.
Importantly, since the core protein and NCp7 are struc-
turally diﬀerent proteins from two diﬀerent virus families,
the conserved nucleic acid chaperone properties suggest
that they are required in a large panel of viruses, in line
with the recently demonstrated conservation of RNA
chaperoning in Flaviviridae core proteins (60). The
potent chaperone properties of the core peptides in the
TAR oligonucleotides model used in this study further
suggest that the core protein is a nucleic chaperone with
broad sequence speciﬁcity. These properties may be
critical for genomic RNA dimerization in HCV replication
and RNA packaging, as well as for facilitating recombi-
nation between various HCV genotypes and subtypes to
increase viral variability (61–63).
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